Medical News

RSS

Study finds early surgical treatment may benefit people who suffer from biceps injuries

People who suffer from injuries to the distal biceps tendon may benefit from earlier surgical intervention and new surgical techniques, according to a review article published in the March 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS).

3 Mar 2010

Study on impact of bystander CPR on pediatric cardiac arrest

Bystanders who perform cardiopulmonary resuscitation (CPR) on a child with cardiac arrest increase the child's likelihood of survival, according to the largest pediatric study to date. The outcomes are similar for both chest compression alone (hands-only) CPR and CPR with chest compression and rescue breathing.

3 Mar 2010

AUA Foundation joins AUA in response to the ACS updated prostate cancer screening guidelines

The American Urological Association Foundation joins the AUA in its response to the American Cancer Society updated prostate cancer screening guidelines highlighting the importance of shared decision-making between patients and physicians.

3 Mar 2010

Democrats seem to gain momentum on health reform, but face many obstacles

As Democratic leaders pursue a go-it-alone strategy on health care, the real test will be whether their caucus can pull together and be effective, according to a Politico analysis.

3 Mar 2010

Shock: Norepinephrine favored over dopamine

Physicians treating patients with shock should consider norepinephrine instead of dopamine as a tool for stabilizing blood pressure, according to an editorial in the March 4, 2010, issue of the New England Journal of Medicine (NEJM).

3 Mar 2010

CPEX Pharmaceuticals' fourth-quarter 2009 revenues up 23%

CPEX Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the year CPEX reported revenues of $18.7 million and a net loss of $3.0 million.

3 Mar 2010

CaridianBCT's Trima Accel Automated Blood Collection System Version 6.0 receives 510(k) clearance

CaridianBCT, a leading global provider of technology, products and services in automated blood collections, therapeutic apheresis and cell therapy systems, whole blood processes and pathogen reduction technologies announced it has received 510(k) clearance for the Trima Accel® Automated Blood Collection System Version 6.0—providing increased efficiencies and streamlined operations to blood centers.

3 Mar 2010

General Nutrition Centers' net income up 56.3% for fourth-quarter 2009

General Nutrition Centers, Inc., a leading global specialty retailer of nutritional products, today reported its financial results for the year and quarter ended December 31, 2009.

3 Mar 2010

AGN-209323 small molecule for neuropathic pain: Bristol-Myers Squibb, Allergan announce global agreement

Bristol-Myers Squibb Company and Allergan, Inc. today announced a global agreement for the development and commercialization of AGN-209323, a Phase II-ready, orally administered small molecule in clinical development for neuropathic pain.

3 Mar 2010

Actemra: 38% of rheumatologists have commenced treatment

BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1 today, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion. The study results are based on an on-line survey completed by 77 rheumatologists in late February.

3 Mar 2010

Survey underscores need for continued efforts to combat substance abuse among teens

New survey data released today by the Partnership for a Drug-Free America and MetLife Foundation point to the need for continued efforts to combat substance abuse among teens. While there was no significant increase in the abuse of over-the-counter (OTC) cough medicines containing dextromethorphan, the 21st annual Partnership/MetLife Foundation Attitude Tracking Survey (PATS) found an overall waning in teens' negative perceptions about many drugs along with increases in abuse rates for alcohol, ecstasy, and marijuana.

3 Mar 2010

POZEN reports net loss of $6.9M for year ended December 31, 2009

POZEN Inc., today announced results for the fourth quarter and year ended December 31, 2009.

3 Mar 2010

Pfizer, Medivation announce results of two dimebon Phase 3 trials in AD patients

Pfizer Inc. and Medivation, Inc. today announced results from two Phase 3 trials of the investigational drug dimebon (latrepirdine) in patients with Alzheimer’s disease (AD). In the CONNECTION trial, dimebon did not meet its co-primary or secondary efficacy endpoints compared to placebo. Co-primary endpoints were measures of cognition and global function.

3 Mar 2010

Spectral Diagnostics receives FDA IDE approval for Toraymyxin

BioMS Medical Corp. today reported that Spectral Diagnostics has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Toraymyxin(TM). Spectral Diagnostics and BioMS have entered into a services agreement whereby BioMS will assist Spectral, as required, in its commercialization of Toraymyxin(TM), a therapeutic hemoperfusion device for the treatment of severe sepsis. This approval permits Spectral to initiate its planned pivotal trial for Toraymyxin(TM) in the United States.

3 Mar 2010

Gene 'addiction' of leukaemia cells

An international team of scientists studying acute forms of Leukaemia have identified a new drug target to inhibit the genes which are vital for the growth of diseased cells. The research, reported in EMBO Molecular Medicine, reveals how leukaemia cells become 'addicted' to genes, which if targeted could prevent diseased cells from developing.

3 Mar 2010

Pennsylvania makes available $400,000 in federal fund to support individuals within criminal justice system

Pennsylvania is making available $400,000 in federal American Recovery and Reinvestment Act funds to provide certified forensic peer support services to individuals within the criminal justice system who are suffering from mental illness, as well as psychiatric and substance abuse disorders.

3 Mar 2010

AHF’s Magic Johnson ‘Testing America’ Tour arrives in Columbia, South Carolina to host free HIV testing events

AHF’s Magic Johnson ‘Testing America’ Tour, a six month, 48 state national cross country HIV testing tour, arrives in Columbia, South Carolina to host free HIV testing events, along with local partner South Carolina HIV/AIDS Council, today and tomorrow, March 3rd and 4th from 10:00 am to 5:00 pm. All are welcome to attend.

3 Mar 2010

Allergan celebrates 20th anniversary of BOTOX in Canada

Twenty years ago, the first approved use of BOTOX(R) (botulinum toxin type A), a neurotoxin widely used to treat several life altering medical conditions, was granted in Canada. As part of the 20th anniversary celebrations, healthcare professionals from coast to coast reflect upon the discovery, science and evolution of a therapy that has impacted the lives of millions of patients worldwide.

3 Mar 2010

Shortage of donated blood in the U.S.: Research looks for ways to improve life-saving supply

There is typically a shortage of donated blood in the United States, and research at Case Western Reserve University is looking for ways of improving the life-saving supply.

3 Mar 2010

Seattle Genetics generates $110M through ADC technology license agreements

Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Genentech, Inc., a wholly owned member of the Roche Group.

3 Mar 2010

Medical News

Study finds early surgical treatment may benefit people who suffer from biceps injuries

Study on impact of bystander CPR on pediatric cardiac arrest

AUA Foundation joins AUA in response to the ACS updated prostate cancer screening guidelines

Democrats seem to gain momentum on health reform, but face many obstacles

Shock: Norepinephrine favored over dopamine

CPEX Pharmaceuticals' fourth-quarter 2009 revenues up 23%

CaridianBCT's Trima Accel Automated Blood Collection System Version 6.0 receives 510(k) clearance

General Nutrition Centers' net income up 56.3% for fourth-quarter 2009

AGN-209323 small molecule for neuropathic pain: Bristol-Myers Squibb, Allergan announce global agreement

Actemra: 38% of rheumatologists have commenced treatment

Survey underscores need for continued efforts to combat substance abuse among teens

POZEN reports net loss of $6.9M for year ended December 31, 2009

Pfizer, Medivation announce results of two dimebon Phase 3 trials in AD patients

Spectral Diagnostics receives FDA IDE approval for Toraymyxin

Gene 'addiction' of leukaemia cells

Pennsylvania makes available $400,000 in federal fund to support individuals within criminal justice system

AHF’s Magic Johnson ‘Testing America’ Tour arrives in Columbia, South Carolina to host free HIV testing events

Allergan celebrates 20th anniversary of BOTOX in Canada

Shortage of donated blood in the U.S.: Research looks for ways to improve life-saving supply

Seattle Genetics generates $110M through ADC technology license agreements

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News